| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |